Carolyn Mulroney

Title(s)Clinical Professor, Medicine
SchoolHealth Sciences
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Clinical Trials
    Co-Investigator on several clinical trials in the Blood and Marrow Transplantation Division: BMTCTN 0402, IRB # 101006, A Phase III Randomized, Multicenter Trial comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as a Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA- Matched, Related Peripheral Blood Stem Cell transplantation.

    Education and Training
    B.A. - University of Pennsylvania, Philadelphia, PA - 1978-1982
    M.D. - Johns Hopkins University School of Medicine - 1982-1986
    Research Fellowship - American Academy of Allergy and Immunology, John Hopkins University School of Medicine Division of Immunology, Durham, Baltimore, Maryland - 1986
    Intern in Internal Medicine - Duke University School of Medicine, Durham, North Carolina - 1986-1987
    Hematology Fellowship - University of Washington, Seattle, Washington - 1990-1992
    Hematology Oncology Fellow - University of California, San Francisco, CA - 1992

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers (Basel). 2018 Dec 21; 11(1). PMID: 30583461.
      View in: PubMed
    2. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney C, Roeland EJ. Transfusion practices at end of life for hematopoietic stem cell transplant patients. Support Care Cancer. 2018 Jun; 26(6):1927-1931. PMID: 29285557.
      View in: PubMed
    3. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney CM, Roeland EJ. Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation. J Oncol Pract. 2017 09; 13(9):e721-e728. PMID: 28644706.
      View in: PubMed
    4. Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017 06; 1. PMID: 28681041.
      View in: PubMed
    5. Li K, Johnson RL, Li S, Thorson JA, Mulroney CM, Dell'Aquila ML, Wang HY. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. Int J Clin Exp Pathol. 2014; 7(8):5221-31. PMID: 25197401.
      View in: PubMed
    6. Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, Shaikh F, Natarajan L. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support Care Cancer. 2011 Dec; 19(12):2015-20. PMID: 21116652.
      View in: PubMed
    7. Mulroney CM, Gl├╝ck S, Ho AD. The use of photodynamic therapy in bone marrow purging. Semin Oncol. 1994 Dec; 21(6 Suppl 15):24-7. PMID: 7992104.
      View in: PubMed